Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
07/2008
07/09/2008EP1465863B1 Potassium channel modulators
07/09/2008CN101218237A Oxime derivative and preparations thereof
07/09/2008CN101215273A Method of producing rubber vulcanization accelerator DM
07/09/2008CN101215272A Method of producing rubber vulcanization accelerator DM
07/09/2008CN101215271A Method of separating rubber vulcanization accelerator MBT
07/09/2008CN101215270A Fluorine-containing benzothiazole sulphuryl compounds and its preparation and application
07/09/2008CN101215269A 2-thiazolylacrylonitrile compounds and its synthetic method and application
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400512C Benzoic acid derivatives as modulators of PPAR alpha and gamma
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/09/2008CN100400041C Diaminothiazoles used as CDK4 inhibitors
07/08/2008US7396943 Opioid receptor antagonists
07/08/2008US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole
07/08/2008US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/08/2008US7396842 Five-membered cyclic compounds
07/08/2008US7396831 Vanilloid receptor ligands and their use in treatments
07/08/2008CA2289535C Homopolymers with high photoinduceable double refraction
07/03/2008WO2008079687A1 Novel compounds as cannabinoid receptor ligands and uses thereof
07/03/2008WO2008079610A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase
07/03/2008WO2008077188A1 Bicyclic pyrimidinones and uses thereof
07/03/2008WO2008043533A3 Acyl aminoimidazoles and acyl aminothiazoles
07/03/2008WO2008019030A3 Modified azole compounds as antiinfective agents
07/03/2008US20080161580 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
07/03/2008US20080161426 p53 Inhibitors and Therapeutic Use of the Same
07/03/2008US20080161371 Modulators of cystic fibrosis transmembrane conductance regulator
07/03/2008US20080161370 Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors
07/03/2008US20080161369 Open label, single arm, two stage, multicenter study; patients who have not responded to taxane/platinum therapy or have relapsed within six months
07/03/2008US20080161368 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
07/03/2008US20080161358 Cyanoamide Compounds Useful as Malonyl-COA Decarboxylase Inhibitors
07/03/2008US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008CA2673183A1 Bicyclic pyrimidinones and uses thereof
07/03/2008CA2672088A1 Glucokinase activator
07/02/2008EP1939189A1 Derivative having ppar agonistic activity
07/02/2008EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents
07/02/2008EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
07/02/2008EP1937656A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as beta 2 adrenoceptor agonists
07/02/2008EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
07/02/2008EP1937637A1 New n-alkyl-heterocyclyl carboxamide derivatives
07/02/2008EP1937631A2 Hiv-1 protease inhibitors
07/02/2008EP1830846A4 Thiazolium compounds and uses thereof
07/02/2008EP1496838A4 Substituted amides
07/02/2008CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
07/01/2008US7393865 Sleep inducing compounds and methods relating thereto
07/01/2008US7393366 Agents for coloring keratin fibers
06/2008
06/26/2008WO2008075184A2 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
06/26/2008US20080154042 Bioavailability, nontoxic; such as 2-(4-dimethylaminophenyl)benzothiazole
06/26/2008US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
06/26/2008US20080153889 Derivatives of 11-nonyloxy-undec-8(Z)-eonic acid, e.g., (Z)- 6-amino-2-(11-(nonyloxy)undec-8-enamido)hexanoic acid; compounds mimic epoxide metabolites; for use in treatment of renal or cardiovascular disease; hypotensive agents
06/26/2008US20080153883 Novel compounds as cannabinoid receptor ligands and uses thereof
06/26/2008US20080153842 Synergistic mixture of a thiazolecarboxamide derivative, especially N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, and an antiproliferative cytotoxic agent such as paclitaxel, procarbazine, mitoxantrone or an epidophyllotoxin
06/26/2008US20080153838 Compounds Having Tie2 (Tek) Activity
06/26/2008US20080152950 Anthracene derivative and organic electroluminescent device using the same
06/25/2008EP1935986A2 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
06/25/2008EP1935869A1 Retinoids for the treatment of emphysema
06/25/2008EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
06/25/2008EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
06/25/2008EP1934192A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors
06/25/2008EP1934187A1 Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors
06/25/2008EP1934186A2 Renin inhibitors nitroderivatives
06/25/2008EP1934178A2 Substituted propylamine derivatives and methods of their use
06/25/2008EP1934169A1 Aldimines comprising reactive groups containing active hydrogen, and use thereof
06/25/2008EP1805153B1 Silane esters and amides of 2-oxothiazolidine-4-carboxylic acid and use thereof for preventing photoageing of the skin
06/25/2008EP1328271B1 Treatment of neurological and neuropsychological disorders
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008CN101208352A Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
06/25/2008CN101208336A Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
06/25/2008CN101208328A Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
06/25/2008CN101208317A New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
06/25/2008CN101208089A 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 Aminothiazole derivatives as human stearoyl desaturase inhibitor -CoA
06/25/2008CN100396672C N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides
06/25/2008CN100396668C Non-imidazole aryloxypiperidines
06/25/2008CN100396182C Biocidal composition and its use
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/24/2008US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine
06/24/2008US7390810 Pyrazole-amine compounds useful as kinase inhibitors
06/19/2008WO2008073936A1 Carboxamide derivatives as ion channel modulators
06/19/2008WO2008073934A1 Ion channel modulators
06/19/2008WO2008073929A1 Ion channel modulators
06/19/2008WO2008073461A2 Ion channel modulators
06/19/2008WO2008072032A1 Transdermal delivery systems of beta-lactam antibiotics
06/19/2008WO2007069020A3 N-hydroxyamide derivatives possessing antibacterial activity
06/19/2008WO2006078621A9 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
06/19/2008US20080146797 Process for synthesizing heterocyclic compounds
06/19/2008US20080146632 Fc Receptor Modulating Compounds and Compositions
06/19/2008US20080146629 Novel thiazolidin-4-one derivatives
06/19/2008US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/19/2008US20080146625 Oxime glucokinase activators
06/19/2008US20080146624 Amidines as modulators of indoleamine 2,3-dioxygenase
06/19/2008US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof
06/19/2008US20080146594 Thrombopoietin activity modulating compounds and methods
06/19/2008US20080145335 Which protect neural cells from degeneration and/or death in response to injury or disease; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease
06/19/2008CA2672239A1 Carboxamide derivatives as ion channel modulators
06/19/2008CA2672236A1 Ion channel modulators
06/19/2008CA2672223A1 Ion channel modulators
06/19/2008CA2671938A1 Transdermal delivery systems of beta-lactam antibiotics
06/18/2008EP1932838A2 Beta-form crystal of acetanilide derivative
06/18/2008EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 337